🇺🇸 FDA
Patent

US 7883881

Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

granted A61PA61P11/06A61P21/04

Quick answer

US patent 7883881 (Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P11/06, A61P21/04, A61P25/00, A61P25/16